CP Cannon

Impact of <i>ADCY9</i> Genotype on Response to Anacetrapib

Jemma C. Hopewell, M Ibrahim, Michael Hill et al. · Circulation · 2019 · 34 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +5

Lower dose heparin with thrombolysis is associated with lower rates of intracranial hemorrhage: results from TIMI 10B and ASSENT I

Robert P. Giugliano, CP Cannon, CH McCabe et al. · Circulation · 1997 · 16 citations

Medicine, Neurosurgery, Pharmacotherapy +15

TNK-tissue plasminogen activator compared with front-loaded tissue plasminogen activator in acute myocardial infarction: primary results of the TIMI 10B trial

CP Cannon, CH McCabe, C. Michael Gibson et al. · Circulation · 1997 · 14 citations

Medicine, Cardiology, Internal Medicine +15

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Chronic Kidney Disease According to Baseline HbA1c, Including Those with HbA1c <7%: Results From the CREDENCE Trial

CP Cannon, Perkovic, Rupesh Agarwal et al. · 2019 · 12 citations

Medicine, Pharmacology, Pharmacotherapy +14